Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma
Conditions: Laryngeal Cancer; Hypopharynx Cancer; Laryngeal Neoplasms Intervention: Drug: chemotherapy TP regimen combined with Toripalimab Sponsor: Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Hypopharyngeal Cancer | Laryngeal Cancer | Research